与衰老相关的多系统疾病中的NPM1:分子机制和治疗影响
Jiayao Li1,2,3, Jiaqi Jin1,2,3, Xinyu Yang1,2,3,4
1Departments of Neurosurgery and Departments of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Aging and disease
|January 12, 2026
概括
核胺1 (NPM1) 是衰老相关疾病的关键调节剂,影响细胞平衡和应激反应. 它的双重作用凸显了针对NPM1信号的特定环境治疗策略的需要.
科学领域:
- 老年学和细胞生物学.
- 老龄化的分子机制.
- 核应激反应途径的核应激反应
背景情况:
- 老龄化人口面临越来越多的癌症,心血管问题和纤维化等疾病.
- 核细胞应激反应,包括核糖体生物发生和DNA修复,对于与年龄相关的疾病发病至关重要.
- 核胺1 (NPM1),一个核伴侣,通过这些途径维持细胞平衡.
研究的目的:
- 审查NPM1在多系统衰老相关疾病的发病和治疗中的作用.
- 探索核应激和细胞平衡中的NPM1相关信号.
- 评估NPM1作为预测生物标志物,并讨论治疗策略.
主要方法:
- 关于NPM1参与与衰老相关疾病的文献综述.
- 对与NPM1相关的信号通路的分析.
- 评估NPM1的生物标志物潜力和治疗向.
主要成果:
- 在瘤发生,血管衰老和纤维化中,NPM1具有疾病特异性的,通常是双重的作用.
- NPM1信号传递是与年龄相关的病理过程和细胞平衡的核心.
- NPM1抑制剂具有治疗潜力,但由于NPM1的双重性质,需要特定的应用.
结论:
- NPM1是与衰老相关的病变发生的中心协调者.
- 针对NPM1信号提供了提高治疗疗效的潜力.
- 了解NPM1的上下文依赖功能对于有效的治疗干预至关重要.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Aging
580
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
580
Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K

